The 2026 guide to CAR-T cell therapy in China — what it really costs, which JCI-accredited hospitals run approved programs, and how escrow protects your payment from first deposit to final milestone.
Updated August 2026. CAR-T (chimeric antigen receptor T-cell) therapy is a living-cell immunotherapy that engineers a patient's own T cells to recognize and attack cancer. In the US, approved CAR-T products list at $400,000–$500,000 before hospital, infusion, and complication costs — routinely crossing $1M all-in. In China, the same class of therapy is delivered at a fraction of that, with multiple approved products and hundreds of clinical trials.
Typical all-in ranges from JCI-accredited partner hospitals, 2025–2026. 'All-in' = hospital, physician, medications, infusion, nursing, room, and coordination — no surprise line items. Last verified: August 2026.
| Item | Typical US price | China all-in | Savings |
|---|---|---|---|
| Commercial CAR-T (list price) | $400,000–$500,000 | $89,000–$170,000 | 65–80% |
| CAR-T all-in (infusion + hospital + follow-up) | $800,000–$1,000,000+ | $120,000–$220,000 | 75–85% |
| Clinical-trial CAR-T (eligibility-based) | N/A (waitlist) | $0–$60,000 (trial-related costs) | varies |
| Bispecific / NK-cell therapies | $300,000+ | $50,000–$110,000 | 70–80% |
China's CAR-T capacity is concentrated in its top JCI-accredited and national-designated cancer centers. Our partner network includes the Cancer Hospital CAMS (Beijing), Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center (Guangzhou), and leading centers in the Hainan Boao Lecheng Pilot Zone, where imported cell-therapy products are legally available under special national policies.
Every hospital in our network holds current accreditation, publishes its clinical-trial and product approvals, and treats international patients through dedicated international departments with English-speaking coordinators.
Eligibility for CAR-T depends on your cancer type (most programs target B-cell malignancies — lymphoma, leukemia, multiple myeloma), prior treatment lines, organ function, and performance status. A physician review of your records is the only way to know. Our free case review gives you an honest answer within 48 hours — if CAR-T isn't right for your case, we'll tell you, and we'll point you to what actually is.
Most medical-travel agencies ask for 100% upfront with no recourse. Verified China Care structures every payment through an independent third-party escrow agent: you fund escrow, funds are released to the hospital in stages tied to documented treatment milestones, and if care is not delivered as agreed, funds stay frozen while the dispute is resolved. You never pay an agent's 30–60% markup, and you never pay for services not rendered.
1. Send your records — a physician reviews eligibility and you get a line-item, all-in quote within 48 hours. 2. You sign a treatment agreement directly with the hospital. 3. You fund escrow (100% protected). 4. Hospital begins treatment; milestones release payments. 5. Discharge, follow-up handoff for your home doctor, and any dispute keeps funds frozen.
Is CAR-T legal in China for international patients?
Yes. Multiple CAR-T products are commercially approved in China (e.g., relma-cel, axi-cel equivalents), and international patients are treated through designated international departments. In the Boao Lecheng Pilot Zone, products not yet launched nationally can be accessed under special policies.
How long does the whole process take?
Records review (48h) → eligibility and quote (1–2 weeks) → visa and travel (2–4 weeks) → leukapheresis and manufacturing (2–4 weeks) → infusion and monitoring (2–6 weeks). Most patients are in China for 6–10 weeks total.
What if my insurance doesn't cover it?
Escrow gives you protection insurance can't: you fund only what the contract specifies, funds release against documented milestones, and anything not delivered stays frozen. Some patients use medical-travel loans; we'll share what we know.
Send your diagnosis and we'll shortlist hospitals and give you a transparent, line-item quote within 24 hours. No obligation, no pressure.
Fields marked * are required. Your information stays private.